Archive for the ‘Type 2 Diabetes’ Category

IP Update
The invention, the patent’s abstract states, “relates to a double-stranded ribonucleic acid for inhibiting the expression of a mutant gene, comprising a complementary RNA strand having a complementary region that is substantially complementary to a portion of the mutant gene, and which is partially complementary to the corresponding wild-type gene.

Study: Longer you sit, the shorter your life
The more Americans engage in one of their favorite pastimes — sitting around — the shorter their average life span, a new study suggests.

www.shop.deathtodiabetes.com www.deathtodiabetes.com Author of “Death to Diabtes” releases new diabetes ebook (PDF) that goes “beyond the book”, and provides more information about superior nutrition, super foods, blood glucose testing, meal planning, etc.

Type II Diabetes can be managed and chances of complications reduced or prevented altogether. Dr. Peter Clarke, Chief of Medicine, The Credit Valley Hospital

USDA examines diabetes benefits of cinnamon
Nutrition researchers from USDA’s Agricultural Research Service (ARS) are purifying, characterizing and evaluating the components of cinnamon and other spices to explore their beneficial effects on insulin levels and related functions.

Could diabetes be in your bones? Link between metabolic disease, bone mass; Breakdown of bone keeps blood sugar in check
Our bones have much greater influence on the rest of our bodies than they are often given credit for, according to two new studies. Both studies offer new insights into the interplay between bone and blood sugar, based on signals sent via insulin and a bone-derived hormone known as osteocalcin.

pcp.onlinemindanao.com Type 2 diabetes mellitus today is a global epidemic, a continuing challenge despite the availability of effective therapeutic agents. Current treatment guidelines emphasize early and aggressive treatment targetting the known pathophysiological defects in type 2 diabetes. Yet the reality in clinical practice shows that fewer than 50% of patients under treatment achieve HbA1c levels even in developed countries. More recently, the addition of incretin-based therapy offers significant solutions to the progressive loss of pancreatic beta cell function and other unmet needs in effective diabetes management. In this session, the role of diminished incretin effects in the metabolic derangements in type 2 diabetes will be reviewed. The mechanism of actions and the therapeutic uses of both incretin enhancers and incretin mimetics will be discussed, highlighting efficacy and safety data since they have been available for use in clinical practice. The role of these agents in addressing earliest defects in glucose homeostasis and postprandial hyperglycemia implies potential of preservation of beta cell function. Incretin-based therapy should clearly be considered as a major part of effective diabetes management in current clinical practice.

www.DeathToDiabetes.com TV interview (WROC, NBC CH8) of author and diabetes educator, DeWayne McCulley, in 2006 with his first book, Death to Diabetes. Pennsylvania State graduate, Xerox engineer, Hughes Aircraft, Urban League math tutor, Eta Kappa Nu honor society, Farrell High School, Shenango Valley

Breakdown of bone keeps blood sugar in check, new study finds
Researchers led by Dr. Gerard Karsenty at Columbia University Medical Center have discovered that the skeleton plays an important role in regulating blood sugar and have further illuminated how bone controls this process. The finding, published in Cell, is important because it may lead to more targeted drugs for type 2 diabetes.

I’m going to overcome my type 2 diabetes. YOU ARE WHAT YOU EAT http:www.rawfor30days.com